White Pine Capital’s Aevi Genomic Medicine, Inc. GNMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-20,000
| Closed | -$27K | – | 230 |
|
|
2017
Q2 | $27K | Hold |
20,000
| – | – | 0.01% | 217 |
|
|
2017
Q1 | $37K | Hold |
20,000
| – | – | 0.02% | 210 |
|
|
2016
Q4 | $104K | Hold |
20,000
| – | – | 0.04% | 201 |
|
|
2016
Q3 | $111K | Hold |
20,000
| – | – | 0.05% | 204 |
|
|
2016
Q2 | $111K | Hold |
20,000
| – | – | 0.05% | 204 |
|
|
2016
Q1 | $88K | Hold |
20,000
| – | – | 0.04% | 203 |
|
|
2015
Q4 | $120K | Hold |
20,000
| – | – | 0.05% | 197 |
|
|
2015
Q3 | $156K | Hold |
20,000
| – | – | 0.07% | 203 |
|
|
2015
Q2 | $123K | Hold |
20,000
| – | – | 0.05% | 202 |
|
|
2015
Q1 | $161K | Hold |
20,000
| – | – | 0.07% | 199 |
|
|
2014
Q4 | $101K | Hold |
20,000
| – | – | 0.03% | 208 |
|
|
2014
Q3 | $104K | Hold |
20,000
| – | – | 0.04% | 213 |
|
|
2014
Q2 | $155K | Hold |
20,000
| – | – | 0.05% | 203 |
|
|
2014
Q1 | $140K | Hold |
20,000
| – | – | 0.05% | 215 |
|
|
2013
Q4 | $120K | Hold |
20,000
| – | – | 0.04% | 226 |
|
|
2013
Q3 | $156K | Hold |
20,000
| – | – | 0.05% | 221 |
|
|
2013
Q2 | $76K | Buy |
+20,000
| New | +$76K | 0.03% | 226 |
|